Cargando…
MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common neuromuscular disorders and has no cure. Due to an unknown molecular mechanism, FSHD displays overlapping manifestations with the neurodegenerative disease amyotrophic lateral sclerosis (ALS). FSHD is caused by aberrant gain of...
Autores principales: | Runfola, Valeria, Giambruno, Roberto, Caronni, Claudia, Pannese, Maria, Andolfo, Annapaola, Gabellini, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591880/ https://www.ncbi.nlm.nih.gov/pubmed/37703175 http://dx.doi.org/10.1016/j.celrep.2023.113120 |
Ejemplares similares
-
WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2023) -
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
por: Mocciaro, Emanuele, et al.
Publicado: (2021) -
P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Salomè, Mara, et al.
Publicado: (2023) -
FSHD: copy number variations on the theme of muscular dystrophy
por: Cabianca, Daphne Selvaggia, et al.
Publicado: (2010) -
Polycomb repressive complex 1 provides a molecular explanation for repeat copy number dependency in FSHD muscular dystrophy
por: Casa, Valentina, et al.
Publicado: (2017)